Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Pharmanutra
ISIN IT0005274094
|WKN A2DU6N
Market cap (in EUR)
791 m
Country
Italy
Sector
Healthcare
Dividend yield
1.47%
Overview
Description
Pharmanutra SpA develops nutraceutical products and medical devices. Its Sucrosomial Iron intends to restore articular and movement ability in osteoarticular affections, consisting of cetilar line. The company was founded by Andrea Lacorte and Roberto Lacorte in 2003 and is headquartered in Pisa, Italy.
Healthcare Healthcare Services Miscellaneous Healthcare Italy
Financials
Key metrics
| Market capitalisation, EUR | 791 m |
| EPS, EUR | 2.19 |
| P/B ratio | 10.5 |
| P/E ratio | 37.3 |
| Dividend yield | 1.47% |
Income statement (2025)
| Revenue, EUR | 132 m |
| Net income, EUR | 20 m |
| Profit margin | 15.19% |
What ETF is Pharmanutra in?
There are 2 ETFs which contain Pharmanutra. All of these ETFs are listed in the table below. The ETF with the largest weighting of Pharmanutra is the Amundi FTSE Italia PMI PIR 2020 UCITS ETF Acc.
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| Amundi FTSE Italia PMI PIR 2020 UCITS ETF Acc | 0.52% | Equity Italy Mid Cap | 167 |
| Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist | 0.05% | Equity Europe Small Cap Climate Change | 585 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.